Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling
Authors
Keywords
Proteases, Atherosclerosis, Immunoblotting, Enzyme-linked immunoassays, Carotid endarterectomy, Atheromas, Extracellular matrix, Macrophages
Journal
PLoS One
Volume 11, Issue 3, Pages e0152474
Publisher
Public Library of Science (PLoS)
Online
2016-04-01
DOI
10.1371/journal.pone.0152474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Matrix Metalloproteinase-13 Predominates Over Matrix Metalloproteinase-8 as the Functional Interstitial Collagenase in Mouse Atheromata
- (2014) Thibaut Quillard et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis
- (2014) J. L. Johnson CARDIOVASCULAR RESEARCH
- Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis
- (2014) Ignatios Ikonomidis et al. Circulation-Cardiovascular Imaging
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
- (2013) Peter Libby NEW ENGLAND JOURNAL OF MEDICINE
- The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles
- (2012) P. Lacolley et al. CARDIOVASCULAR RESEARCH
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- IL-1 and atherosclerosis: a murine twist to an evolving human story
- (2011) Daniel J. Rader JOURNAL OF CLINICAL INVESTIGATION
- Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
- (2011) Matthew R. Alexander et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia But Not Inflammation Augments Glucose Uptake in Human Macrophages
- (2011) Eduardo J. Folco et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Inflammation and Cardiovascular Disease
- (2008) William F. Fearon et al. CIRCULATION
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started